Cyclobenzaprine and diclofenac are not known to have a direct drug-drug interaction, and they are commonly prescribed alongside each other for musculoskeletal pain with muscle spasm. Clinical guidelines for acute back and neck pain actually endorse the general strategy of pairing an NSAID with a muscle relaxant. That said, the combination is not risk-free, and the side-effect profiles of each drug overlap in ways that deserve attention, particularly around drowsiness, gastrointestinal irritation, and cardiovascular health.
Why These Two Drugs Are Often Paired
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that works by blocking COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins, the chemical messengers that drive inflammation and pain signaling.1PubMed Central. Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology Cyclobenzaprine is a centrally acting muscle relaxant. Its structure is nearly identical to the tricyclic antidepressant amitriptyline, and it works primarily in the brain and spinal cord by acting on several receptor types, including serotonin, histamine, and muscarinic receptors.2PubMed Central. Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System Because one targets inflammation in the tissues while the other targets muscle spasm through the central nervous system, they address different parts of the pain picture without competing for the same biological pathway.
This is the logic that makes the pairing appealing for conditions like acute low back pain: the NSAID quiets inflammation and the muscle relaxant eases the involuntary tightening that often accompanies it. Russian Society for the Study of Pain guidelines, for example, recommend both NSAIDs at the lowest effective dose and muscle relaxants for acute musculoskeletal low back pain.3Neurology, Neuropsychiatry, Psychosomatics. Acute nonspecific (musculoskeletal) low back pain Guidelines of the Russian Society for the Study of Pain (RSSP) Similar recommendations appear in American and European back pain guidelines. The two drugs do not interfere with each other’s absorption or metabolism in a clinically meaningful way, so there is no pharmacokinetic reason to avoid the combination.
Does Adding an NSAID to Cyclobenzaprine Actually Help More?
The intuitive assumption is that two drugs should work better than one. The clinical evidence for this specific question is surprisingly lukewarm. A randomized trial of over 860 patients with acute neck or back pain and muscle spasm tested cyclobenzaprine alone against cyclobenzaprine combined with ibuprofen (a close relative of diclofenac in the NSAID family). After seven days, the combination was not superior to cyclobenzaprine alone on the study’s primary measure of improvement. All groups improved significantly from baseline, but there were no meaningful differences between them.4Current Medical Research and Opinion. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: A randomized trial
This does not mean adding diclofenac is pointless in every situation. The trial used low-dose cyclobenzaprine (5 mg three times daily) with either 400 mg or 800 mg of ibuprofen, and the patient population had acute pain, which tends to improve on its own over days to weeks regardless of treatment. In someone with a stronger inflammatory component, or in conditions where the NSAID is the primary therapy and cyclobenzaprine is the add-on, the balance might tip differently. But the study is a useful reminder that stacking medications does not always translate into stacking benefits, and each additional drug does carry additional risk.
Side Effects That Overlap
When you take both drugs together, you are not dealing with a new interaction so much as the combined burden of two separate side-effect profiles. Some of those profiles overlap in ways that matter.
Drowsiness is the most obvious overlap. Cyclobenzaprine causes significant sedation because of its antihistamine and anticholinergic properties. Diclofenac can also cause dizziness and lightheadedness in some people, though this is less common. Together, the effect on alertness and reaction time can be more pronounced than either drug alone. Driving or operating machinery while taking both deserves extra caution, especially during the first few days before you know how the combination affects you.
Gastrointestinal discomfort is the other major area of concern. Diclofenac is well-documented as a stomach irritant. Cyclobenzaprine can cause nausea and dry mouth through its anticholinergic effects. Neither drug alone is necessarily a problem for most people over a short course, but the combination can make GI symptoms more bothersome, particularly if you are not eating with your doses or are using higher doses of the NSAID.
Diclofenac’s Gastrointestinal and Cardiovascular Risks
Whether you are taking cyclobenzaprine alongside it or not, diclofenac carries risks that are worth understanding clearly. A large Danish nationwide cohort study found that starting diclofenac increased the risk of upper gastrointestinal bleeding roughly four-and-a-half-fold compared to not starting any NSAID, and about two-and-a-half-fold compared to starting ibuprofen or acetaminophen.5BMJ. Diclofenac use and cardiovascular risks: series of nationwide cohort studies That same study also documented increased cardiovascular event rates. These are population-level findings, so the absolute risk for any individual person remains small over a short course, but they explain why diclofenac has been moved behind the counter or restricted to prescription-only in several countries.
A meta-regression analysis of systematic review data confirmed that both the gastrointestinal and cardiovascular risks of diclofenac scale with dose, meaning higher daily doses carry proportionally more risk.6PubMed. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews This dose-response relationship is one of the strongest arguments for using the lowest dose that controls your symptoms and keeping the course as short as possible. Adding cyclobenzaprine does not directly worsen diclofenac’s cardiovascular or GI risk through a pharmacological interaction, but it does not cancel it out either.
If you have a history of stomach ulcers, GI bleeding, heart disease, or stroke, taking diclofenac at all requires a careful conversation with your prescriber. Adding a second medication to the mix makes that conversation more relevant, not less.
Cyclobenzaprine and Serotonin Syndrome
Cyclobenzaprine’s most serious interaction risk has nothing to do with NSAIDs. Because cyclobenzaprine blocks serotonin and norepinephrine transporters and binds to multiple serotonin receptors, it can contribute to serotonin syndrome when combined with other drugs that raise serotonin levels.7PubMed Central. Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome Serotonin syndrome is a potentially dangerous condition that can cause agitation, rapid heart rate, high blood pressure, muscle rigidity, and in severe cases, life-threatening complications.
Published case reports describe severe serotonin syndrome in patients who were given cyclobenzaprine while already taking another serotonergic drug. In the reported cases, the other drugs were phenelzine (an older antidepressant known as an MAO inhibitor) and duloxetine (a modern antidepressant used for both depression and pain).8PubMed. Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs The authors of that report concluded that cyclobenzaprine should be used with extreme caution in anyone taking serotonin-enhancing medications.
Diclofenac is not a serotonergic drug, so this particular risk does not apply to the cyclobenzaprine-diclofenac combination specifically. But it matters practically because many people who are prescribed this pair for musculoskeletal pain are also taking an antidepressant, a migraine medication like a triptan, or tramadol for additional pain control. If that describes you, the cyclobenzaprine is the drug that deserves extra scrutiny, and your pharmacist or prescriber should review your full medication list before you start it.
Topical Diclofenac as a Safer Route
One of the most practical ways to reduce interaction risk when combining medications is to take one of them in a form that limits how much reaches the bloodstream. Diclofenac is available as a topical gel (commonly sold under brand names like Voltaren), and the systemic absorption from applying it to the skin over a joint is much lower than from swallowing a tablet.
A study specifically examining topical diclofenac gel used alongside medications known to interact with oral diclofenac found that the topical form was associated with only a small increase in adverse events during concomitant use. The researchers concluded that reducing the NSAID dose through a topical route may mitigate the risk of clinically evident problems from potential drug interactions.9PubMed Central. Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac For someone with localized pain in a knee, shoulder, or wrist who is also taking cyclobenzaprine for spasm, applying diclofenac gel to the affected area rather than taking oral tablets gives you the anti-inflammatory benefit at the pain site with much less systemic exposure. The trade-off is that topical diclofenac works best for superficial joints and does not reach deeper structures like the lumbar spine very effectively, so it is not a universal substitute for the oral form.
How Well Does Cyclobenzaprine Actually Work?
It is worth stepping back and asking whether cyclobenzaprine is earning its place in this pairing. An analysis pooling data from randomized studies of seven different skeletal muscle relaxants found that none of them, cyclobenzaprine included, produced improvement that was statistically different from placebo on a validated disability questionnaire. On top of that, cyclobenzaprine was associated with significantly more side effects than placebo.10PubMed. The Relative Efficacy of Seven Skeletal Muscle Relaxants. An Analysis of Data From Randomized Studies The mean improvement scores across all relaxants and placebo were remarkably similar, hovering around a 10-point gain.
This does not mean cyclobenzaprine is useless. The studies focused on disability scores in acute low back pain, which, as mentioned earlier, tends to improve substantially on its own. Cyclobenzaprine may still help with subjective symptoms like nighttime spasm and difficulty sleeping, since its sedating properties can be leveraged for that purpose. Some clinicians prescribe it primarily as a bedtime medication for patients whose pain disrupts sleep. But the evidence suggests that if you are tolerating the side effects of both drugs and not getting obvious relief, dropping the cyclobenzaprine is a reasonable thing to discuss with your doctor. The NSAID alone may be doing most of the heavy lifting.
Kidney and Liver Considerations
Both cyclobenzaprine and diclofenac are processed through the liver. Cyclobenzaprine is metabolized extensively by the same family of liver enzymes that handle many other drugs, and its half-life can stretch significantly in people with reduced liver function. Diclofenac, while generally well tolerated in normal liver function, has been associated with rare but serious liver injury. Taking both drugs simultaneously puts a higher workload on the liver than either drug alone, which is mostly a concern for people who already have compromised liver function, drink alcohol regularly, or are taking other hepatically metabolized medications.
The kidney angle matters too. All oral NSAIDs, diclofenac included, reduce blood flow to the kidneys by blocking prostaglandins. In someone with healthy kidneys taking a short course, this is rarely a problem. But in older adults, people with chronic kidney disease, or those taking blood pressure medications that also affect kidney perfusion (ACE inhibitors, ARBs, or diuretics), adding diclofenac to the mix raises the risk of acute kidney injury. Cyclobenzaprine itself is not directly nephrotoxic, but its sedation can contribute to dehydration if you are not drinking enough water, which compounds the kidney-related risks of the NSAID. Staying well hydrated while taking this combination is not just general wellness advice; it directly matters for renal safety.
Who Should Avoid This Combination
There is no blanket prohibition against taking cyclobenzaprine with diclofenac, but certain situations make the combination a poor fit:
- Older adults: Both drugs are on various cautionary lists for people over 65. Cyclobenzaprine’s anticholinergic effects (confusion, urinary retention, constipation, dry mouth) are more pronounced in older adults, and diclofenac’s GI and cardiovascular risks climb with age. Many geriatricians prefer to avoid this pairing altogether.
- People on blood thinners: Diclofenac increases bleeding risk on its own. Combined with anticoagulants like warfarin or direct oral anticoagulants, the GI bleeding risk is amplified. Cyclobenzaprine does not directly affect clotting, but its sedation can mask early symptoms of a bleed.
- People with heart failure or uncontrolled hypertension: NSAIDs promote fluid retention and can worsen blood pressure control and heart failure symptoms. This is a diclofenac issue, not a cyclobenzaprine issue, but it still means the combination is inappropriate for these patients.
- People taking SSRIs, SNRIs, or MAO inhibitors: The serotonin syndrome risk from cyclobenzaprine makes the muscle relaxant the problem here, not diclofenac. Your prescriber may opt for a different muscle relaxant or skip the relaxant entirely.
Practical Tips if You Are Taking Both
If your doctor has prescribed both cyclobenzaprine and diclofenac and you are otherwise a reasonable candidate for the combination, a few practical steps can help minimize risk. Take diclofenac with food to reduce stomach irritation. If you are only using the NSAID for localized joint or muscle pain, ask whether the topical gel form might work for your situation, since it carries less systemic risk. Take cyclobenzaprine at bedtime rather than throughout the day if your prescriber agrees; this turns its sedating side effect into a sleep benefit and keeps daytime drowsiness to a minimum.
Keep the course short. Both drugs are intended for short-term use in acute musculoskeletal conditions, typically one to two weeks. The risks of both medications rise with prolonged use: GI and cardiovascular risks for diclofenac, and diminishing effectiveness paired with persistent sedation for cyclobenzaprine. If your pain has not improved substantially after two weeks, the answer is usually to reassess the diagnosis and treatment plan, not to continue both drugs indefinitely.
Finally, keep your pharmacist in the loop. Pharmacists run automated interaction checks, but these systems flag the known interactions of each drug individually, not always the cumulative side-effect burden of a combination. Mentioning that you are taking both, along with everything else in your medicine cabinet, gives the pharmacist a chance to flag anything the automated system might miss.
Alcohol and This Combination
Alcohol deserves its own mention because it intersects with both drugs’ risk profiles. Alcohol amplifies cyclobenzaprine’s sedation, sometimes dramatically. Even one or two drinks can turn a manageable drowsiness into impaired coordination and judgment. On the diclofenac side, alcohol irritates the stomach lining independently, and the combination of alcohol plus an NSAID raises the risk of GI bleeding beyond what either would cause alone. And because both drugs are liver-metabolized, alcohol adds a third agent competing for the same detoxification pathways. The short version: if you are taking both of these medications, even socially moderate drinking becomes riskier than it would normally be. Most prescribers advise avoiding alcohol entirely during a course of cyclobenzaprine, and that advice becomes even more relevant when diclofenac is in the picture.